全文获取类型
收费全文 | 42613篇 |
免费 | 2203篇 |
国内免费 | 149篇 |
专业分类
耳鼻咽喉 | 570篇 |
儿科学 | 2665篇 |
妇产科学 | 739篇 |
基础医学 | 5204篇 |
口腔科学 | 1183篇 |
临床医学 | 3008篇 |
内科学 | 7575篇 |
皮肤病学 | 1171篇 |
神经病学 | 2600篇 |
特种医学 | 1323篇 |
外科学 | 6317篇 |
综合类 | 1319篇 |
一般理论 | 17篇 |
预防医学 | 2346篇 |
眼科学 | 1489篇 |
药学 | 4240篇 |
1篇 | |
中国医学 | 354篇 |
肿瘤学 | 2844篇 |
出版年
2023年 | 341篇 |
2022年 | 975篇 |
2021年 | 1645篇 |
2020年 | 909篇 |
2019年 | 1022篇 |
2018年 | 1429篇 |
2017年 | 1068篇 |
2016年 | 1394篇 |
2015年 | 1394篇 |
2014年 | 2056篇 |
2013年 | 2322篇 |
2012年 | 3303篇 |
2011年 | 3227篇 |
2010年 | 1917篇 |
2009年 | 1520篇 |
2008年 | 2206篇 |
2007年 | 2218篇 |
2006年 | 2044篇 |
2005年 | 1819篇 |
2004年 | 1670篇 |
2003年 | 1436篇 |
2002年 | 1227篇 |
2001年 | 827篇 |
2000年 | 760篇 |
1999年 | 640篇 |
1998年 | 278篇 |
1997年 | 224篇 |
1996年 | 232篇 |
1995年 | 194篇 |
1994年 | 166篇 |
1993年 | 146篇 |
1992年 | 394篇 |
1991年 | 373篇 |
1990年 | 397篇 |
1989年 | 374篇 |
1988年 | 318篇 |
1987年 | 276篇 |
1986年 | 262篇 |
1985年 | 247篇 |
1984年 | 199篇 |
1983年 | 140篇 |
1982年 | 79篇 |
1981年 | 84篇 |
1980年 | 78篇 |
1979年 | 131篇 |
1978年 | 81篇 |
1977年 | 104篇 |
1976年 | 75篇 |
1973年 | 79篇 |
1971年 | 76篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
S M Kaul V K Raina R D Joshi C N Koya A Kumar T Verghese 《The Journal of communicable diseases》1992,24(1):16-19
A filariasis survey carried out about eight years after achieving zero microfilaria (mf) rates following administration of diethylcarbamazine (DEC) medicated salt in the Kani hill tribe settlements in Quilon and Thiruvananthapuram districts of Kerala State revealed that there was no reappearance of Brugia malayi infection in the experimental areas. Mf rates were maintained at zero level in the experimental villages, while in the control villages, 2.9 per cent mf positives were observed. Mansonia (Mansonioides) uniformis dissected did not reveal filarial infection. It is concluded that DEC medicated salt regime in the experimental areas of Kani hill tribe settlements has been successful in effectively interrupting B. malayi transmission. Pilot studies in other B. malayi endemic areas of India using DEC medicated salt regime with the objective of eliminating B. malayi transmission are advocated, since the parasite has a restricted distribution in India and is already showing a declining trend. 相似文献
992.
993.
S Kumar T F Carr D I Evans P Morris-Jones I M Hann 《Clinical and laboratory haematology》1979,1(2):121-128
Examination of surface markers on leukaemic blasts from 51 children with ALL revealed that ALL is a heterogeneous disease. The majority (68%) of patients with ALL lack surface markers (null leukaemia); 28% could be classed as T cell as they form rosettes with sheep RBC and 4% have been shown to possess surface immunoglobulins and hence are classed as B cells. The children with null cell leukaemia have a better prognosis than T and B cell types. 相似文献
994.
Srivenu?Itha Ashish?Kumar Sadhna?Dhingra Gourdas?ChoudhuriEmail author 《BMC gastroenterology》2003,3(1):21
Background
Dapsone can rarely cause a hypersensitivity reaction called dapsone syndrome, consisting of fever, hepatitis, exfoliative dermatitis, lymphadenopathy and hemolytic anemia. Dapsone syndrome is a manifestation of the DRESS (drug rash with eosinophilia and systemic symptoms) syndrome which is a serious condition that has been reported in association with various drugs. Cholangitis in dapsone syndrome has not been reported so far in the world literature.Case presentation
We report a patient who presented with fever, exfoliative dermatitis, jaundice and anemia within three weeks of starting of dapsone therapy. These features are typical of dapsone syndrome, which is due to dapsone hypersensitivity and is potentially fatal. Unlike previous reports of hepatitic or cholestatic injury in dapsone syndrome we report here a case that had cholangitic liver injury. It responded to corticosteroids.Conclusion
We conclude that cholangitis, though unusual, can also form a part of dapsone syndrome. Physicians should be aware of this unusual picture of potentially fatal dapsone syndrome.995.
Aadish Rawat Parikshit Singh Anupam Jyoti Sanket Kaushik Vijay Kumar Srivastava 《Chemical biology & drug design》2020,96(2):731-744
Amoebiasis is a parasitic infectious disease caused by the enteric protozoan Entamoeba histolytica, a leading basis of deaths accounted to parasites, succeeding malaria and schistosomiasis. Conventional treatment methodologies used to deal with amoebiasis mainly rely on the administration of anti‐amoebic compounds and vaccines but are often linked with substantial side‐effects on the patient. Besides, cases of development of drug resistance in protozoans have been recorded, contributing further to the reduction in the efficiency of the treatment. Loopholes in the efficacious management of the disease call for the development of novel methodologies to manage amoebiasis. A way to achieve this is by targeting the essential metabolic processes of ‘encystation’ and ‘excystation’, and the associated biomolecules, thus interrupting the biphasic life cycle of the parasite. Technologies like the CRISPR‐Cas9 system can efficiently be exploited to discover novel and essential molecules that regulate the protozoan's metabolism, while efficiently manipulating and managing the known drug targets, leading to an effective halt and forestall to the enteric infection. This review presents a perspective on these essential metabolic processes and the associated molecules that can be targeted efficaciously to prevent the transmission of amoebiasis, thus managing the disease and proving to be a fruitful endeavour. 相似文献
996.
997.
998.
999.
1000.
Paul S. Foster Maximilian Plank Adam Collison Hock L. Tay Gerard E. Kaiko JingJing Li Sebastian L. Johnston Philip M. Hansbro Rakesh K. Kumar Ming Yang Joerg Mattes 《Immunological reviews》2013,253(1):198-215
Chronic inflammatory diseases of the lung are leading causes of morbidity and mortality worldwide. Many of these disorders can be attributed to abnormal immune responses to environmental stimuli and infections. As such, understanding the innate host defense pathways and their regulatory systems will be critical to developing new approaches to treatment. In this regard, there is increasing interest in the role of microRNAs (miRNAs) in the regulation of pulmonary innate host defense responses and the inflammatory sequelae in respiratory disease. In this review, we discuss recent findings that indicate an important role for miRNAs in the regulation in mouse models of various respiratory diseases and in host defense against bacterial and viral infection. We also discuss the potential utility and limitations of targeting these molecules as anti-inflammatory strategies and also as a means to improve pathogen clearance from the lung. 相似文献